Anzeige
Erschienen in:
08.03.2024 | Short Communication
Leishmaniasis in otorhinolaryngology: an emerging disease and its relationship with anti-tumor necrosis factor-alpha drugs
Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 5/2024
Einloggen, um Zugang zu erhaltenAbstract
Purpose
To investigate the clinical manifestations, management and outcomes of Leishmania lesions in the ear–nose–throat (ENT) region, and its relationship with tumor necrosis factor (TNF)-α blocking drugs.
Methods
Single-center retrospective observational study. Patients diagnosed with cutaneous and mucosal leishmaniasis in the otorhinolaryngologic area at a tertiary referral center over a period of 8 years.
Results
Three cases of Leishmania lesions in the ear and two in the nose were encountered at our institution. All patients were under treatment with TNF-α blocking drugs. Diagnosis was challenging, and it was important to have a clinical suspicion in order to use accurate detection techniques. All patients received systemic treatment and achieved a complete resolution of the lesions.
Conclusions
With the increasing use of biologic treatments like TNF-α blockers, this type of infection will be increasingly frequent in endemic areas and also worldwide. It is important to include leishmaniasis in the differential diagnosis of inflammatory/infectious lesions in the ENT region.